Trademark: 90628289
Word
POSJELTY
Status
Pending
Status Code
733
Status Date
Wednesday, January 31, 2024
Serial Number
90628289
Mark Type
4000
Filing Date
Wednesday, April 7, 2021
Published for Opposition
Tuesday, January 4, 2022

Trademark Owner History
UroGen Pharma Ltd. - Owner At Publication

Classifications
5 pharmaceutical preparations and compositions for the treatment of bladder cancer

Trademark Events
Feb 2, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 31, 2024
Sou Extension 4 Granted
Jan 31, 2024
Sou Extension 4 Filed
Jan 31, 2024
Sou Teas Extension Received
Aug 23, 2023
Assignment Of Ownership Not Updated Automatically
May 10, 2023
Notice Of Approval Of Extension Request E-Mailed
May 8, 2023
Sou Extension 3 Granted
May 8, 2023
Sou Extension 3 Filed
May 8, 2023
Sou Teas Extension Received
Feb 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 7, 2023
Sou Extension 2 Granted
Feb 7, 2023
Sou Extension 2 Filed
Feb 7, 2023
Sou Teas Extension Received
Aug 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 12, 2022
Sou Extension 1 Granted
Aug 12, 2022
Sou Extension 1 Filed
Aug 12, 2022
Sou Teas Extension Received
Mar 1, 2022
Noa E-Mailed - Sou Required From Applicant
Jan 4, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 4, 2022
Published For Opposition
Dec 15, 2021
Notification Of Notice Of Publication E-Mailed
Nov 24, 2021
Approved For Pub - Principal Register
Nov 24, 2021
Assigned To Examiner
Jul 14, 2021
New Application Office Supplied Data Entered
Apr 10, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24